| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.37 | 0.07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.07 |